| Automated paper screening for clinical reviews using large language models: Data analysis study E Guo, M Gupta, J Deng, YJ Park, M Paget, C Naugler Journal of Medical Internet Research 26, e48996, 2024 | 21 | 2024 |
| Long noncoding RNAs associated with phenotypic severity in multiple sclerosis M Gupta, K Martens, LM Metz, APJ de Koning, G Pfeffer Multiple Sclerosis and Related Disorders 36, 101407, 2019 | 19 | 2019 |
| Colchicine Myopathy: A Case Series Including Muscle MRI and ABCB1 Polymorphism Data M Gupta, A Nikolic, D Ng, K Martens, H Ebadi, S Chhibber, G Pfeffer Frontiers in Neurology 10, 553, 2019 | 15 | 2019 |
| Assessing the research landscape and clinical utility of large language models: A scoping review YJ Park, A Pillai, J Deng, E Guo, M Gupta, M Paget, C Naugler BMC Medical Informatics and Decision Making 24 (1), 72, 2024 | 10 | 2024 |
| neuroGPT-X: towards an accountable expert opinion tool for vestibular schwannoma E Guo, M Gupta, S Sinha, K Rössler, M Tatagiba, R Akagami, O Al-Mefty, ... medRxiv, 2023.02. 25.23286117, 2023 | 8 | 2023 |
| Phylogenetic and ancestral sequence reconstruction of SARS-CoV-2 reveals latent capacity to bind human ACE2 receptor E Brintnell, M Gupta, DW Anderson Journal of Molecular Evolution 89 (9), 656-664, 2021 | 6 | 2021 |
| neuroGPT-X: toward a clinic-ready large language model E Guo, M Gupta, S Sinha, K Rössler, M Tatagiba, R Akagami, O Al-Mefty, ... Journal of Neurosurgery 140 (4), 1041-1053, 2023 | 5 | 2023 |
| Development and validation of a prognostic risk model for patients with advanced melanoma treated with immune checkpoint inhibitors I Stukalin, V Navani, M Gupta, Y Ruan, DJ Boyne, DE O’Sullivan, ... The Oncologist 28 (9), 812-822, 2023 | 3 | 2023 |
| Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors S Samnani, F Sachedina, M Gupta, E Guo, V Navani Cancer Drug Resistance 6 (2), 416, 2023 | 3 | 2023 |
| Development and validation of a 21-gene prognostic signature in neuroblastoma M Gupta, S Kannappan, M Jain, D Douglass, R Shah, P Bose, ... Scientific Reports 13 (1), 12526, 2023 | 2 | 2023 |
| Trends in health care spending on kidney cancer in the United States, 1996–2016 K Takemura, NS Ahmed, I Stukalin, M Gupta, C Ma, DYC Heng Cancer 129 (14), 2161-2168, 2023 | 2 | 2023 |
| Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced Melanoma M Gupta, I Stukalin, D Meyers, S Goutam, DYC Heng, T Cheng, J Monzon, ... JAMA network open 6 (6), e2319607-e2319607, 2023 | 2 | 2023 |
| High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus–specific T-cell counts M Gupta, S Kannappan, A Kalra, C Lam, P Dharmani-Khan, T Williamson, ... Cytotherapy 21 (8), 886-894, 2019 | 2 | 2019 |
| Expression of risk genes linked to vitamin D receptor super-enhancer regions and their association with phenotype severity in multiple sclerosis SM Orton, A Sangha, M Gupta, K Martens, LM Metz, APJ de Koning, ... Frontiers in Neurology 13, 1064008, 2022 | 1 | 2022 |
| Detailed phylogenetic analysis of SARS-CoV-2 reveals latent capacity to bind human ACE2 receptor E Brintnell, M Gupta, DW Anderson bioRxiv, 2020.06. 22.165787, 2020 | 1 | 2020 |
| In vitro investigation demonstrates IGFR/VEGFR receptor cross talk and potential of combined inhibition in pediatric central nervous system atypical teratoid rhabdoid tumors H Obaid, S Kannappan, M Gupta, Y Ruan, C Zhang, P Bose, A Narendran Current Cancer Drug Targets 20 (4), 295-305, 2020 | 1 | 2020 |
| Targeting Oncogenic Polyamines in Refractory Pediatric Leukemias Using the Anti-Protozoan Drug α-Difluoromethylornithine (DFMO) in Combination With GC7 and Aurothioglucose B Hofmann, S Kannappan, G Mehul, C Zhang, S Chi, D Hanson, ... Blood 132, 2725, 2018 | 1 | 2018 |
| EFFECTIVENESS AND SAFETY OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR RESIDUAL OR RECURRENT COLORECTAL NEOPLASIA: A META-ANALYSIS M Eisele, A Ceccacci, M Gupta, E Heer, P Belletrutti, P Kumar, R Gill, ... Gastrointestinal Endoscopy 99 (6), AB590-AB591, 2024 | | 2024 |
| Development of a novel risk stratification model for immune-related adverse events for patients with advanced melanoma and non-small cell lung cancer treated with immune … YK Gao, A Tran, M Gupta, DYC Heng, T Cheng, I Stukalin, DE Meyers, ... Journal of Clinical Oncology 42 (16_suppl), 2649-2649, 2024 | | 2024 |
| P. 070 Using AI to revolutionize clinical training through OSCE-GPT: a focused exploration of user feedback on otolaryngology and neurology cases R Ramchandani, SG Biglou, M Gupta, E Guo Canadian Journal of Neurological Sciences 51 (s1), S35-S35, 2024 | | 2024 |
